A new UK company, Infirst Healthcare, that is developing new versions of existing cough, cold and pain medicines has raised £25 million from Invesco Asset Management Ltd to launch its first product in Europe and to complete development of a second. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
